Wegener's granulomatosis;Granulomatose de Wegener

Anais Brasileiros de Dermatologia

Volumn 73, Issue 2, 1998, Pages 135-141

  Taborda, Paulo Rogério Oldani ^a,b,c,d   Alvares Taborda, Valeria Brega ^a,c  

^a INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^b Sagrado Coração University

^c Universidad de Texas   (United States)

^d NONE   (Brazil)

Author keywords

Vasculitis; Wegener's granulomatosis

Indexed keywords

ADULT; ARTHRALGIA; CLINICAL ARTICLE; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; PROGNOSIS; REVIEW; SKIN MANIFESTATION; SKIN NODULE; TREATMENT PLANNING; ULCER; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 7144261706     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Wegener F. Uber generalisierte septishe gefasserkrankungen. Verh Dtsch Ges Pathol 1936;29:202-10.
2. Chyu JYH, Hagstrom WJ, Soltani K et al. Wegener's granulomatosis in Childhood. J Am Acad Dermatol 1984;10:341-6.
3. Kavanagh GM, Calaco CB, Bradfild JW, Archer CB. Eritema elevatum diutinum associated with Wegener's granulomatosis and IgA paraproteinemia J Am Acad Dermatol 1993;28(5 pt 2):846-9.
4. George J, Levy Y, Kallenberg CG, Shoenfeld Y. Infections and Wegeners granulomatosis - a cause and effect relationship? Q J M 1997;90(5):367-73.
5. Mangold MC, Callen JP. Cutaneous leukocytoclastic vasculite associated with active Wegener's granulomatosis. J Am Acad Dermatol 1992;26(4):579-84.
6. Soukiasian SH, Jakobiec FA, Niles JL. Trimethoprim-sulfametnoxazole for escleritis associated with limited Wegener's granulomatosis: use of histopathology and anti-neutriphil cytoplasmic antibody (ANCA) test. Cornea 1993;12(2):174-80.
7. Fleury RN, Taborda PRO, Opromolla DVA. Granulomatose de Wegener e hanseníase: apenas uma associação fortuita? Hansenol Internationalis 1997;22(1):43-53.
8. Sibilia J, Benlagha K, Vanhille P, Ronco P, Brouet JC, Mariette X. Strutural analysis of human antibodies proteinase 3 from patients with Wegener'.s granulomatosis. J Immunol 1997;159:712-9.
9. Tomer Y, Lider O, Gibburd B et al. Anti-neutrophil cytoplasmic antibody-enriched IgG induces adhesion of human T lymphocytes to extracellular matrix proteins. Clin Imm Immunopath 1997;83(3):245-53.
10. Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross WL. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997;102(6):517-23.
11. Mroowka C, Sieberth HG. Circulating adhesion moleculars ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erytematosus. Clin Investig 1994;72(10):762-8.
12. Lotti T, Comacchi C, Ghersetich. Cutaneous necrotizing vasculitis. Int J Dermatol 1996;35(7):457-68.
13. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Arth Rheum 1996;39(1):87-92.
14. Rottern M, Fauci AS, Hallahan CW et al. Wegener granulomatosis in children and adolescent: clinical presentation and outcome. J Pediatr 1993;122(1):26-31.
15. Krafcik SS, Covin RB, Lynch JP 3rd, Sitrin RG. Wegener's granulomatosis in the elderly. Chest 1996;109(2):430-7.
16. Andrassy K. Rapidly progressive glomerulonephritis and Wegener's granulomatosis. Nephrologie 1992;13(6):279-81.
17. Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyanna Y. The association between human leukocytes antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (c-ANCA)-positive Wegener's granulomatosis in a Japanese population. Rhinology 1996;34(3):163-5.
18. Lie JT Illustrated histopathologic classification criteria for selected vasculitis syndromes Arthritis Rheum 1990;33(8):1074-87.
19. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
20. Fernandes NC, Cardoso ICL, Serpa SS, Rettore FC, Maceira J. Granulomatose de Wegener localizada: relato de caso. An bras Dermatol 1996;71(1):41-4
21. Leavitt RY, Fauci AS, Block DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
22. Matteson EL, Gold KN, Bloch DA, Hunger GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort. Am J Med 1996;101:129-34.
23. Chu P, Connolly MK, Le Boit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular diseases. Arch Dermatol 1994;130:1278-83.
24. Bajema IM, Hagen EC, Wonde FJ, Bruijin JA. Wegener's granulomatosis: meta-analysis of 349 literary case reports. J Lab Clin Med 1997;129(1);17-22.
25. Francès C, Du LT , Piette JC et al. Wegener's granulomatosis: dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994;130(7):861-7.
26. Rabinowitz LO, Zaim MT. Clinicopathologic approach to granulomatous dermatoses. J Am Acad Dermatol 1997;35(4):588-600.
27. Jennete CJ, Milling DM, Falk RJ et al. Vasculitis affecting the skin: a review. Arch Dermatol 1994;130:899-906.
28. Fernandes SRM, Furuie SHW, Amstalden EMI et al. Wegener's granulomatosis and chondritis of the ear. Rev Bras Reumatol 1994;34(4):203-5.
29. Long D, Thiboutot DM, Majeski JT, Vasily DB, Helm KF. Interstitial granulomatous dermatitis with arthritis. J Am Acad Dermatol 1996;34:957-61.
30. Israelson H, Binnie WH, Hurt WC. The hyperplastic gingivitis of Wegener's granulomatosis. J Periodontol 1981;52:81-7.
31. Specks V, Colby TV, Olsen KD, De Remme RA. Salivary gland involvement in Wegener's granulomatosis. Arch Otolaryngol Head Neck Surg 1991;117(2):218-23.
32. Mc Donald TJ, De Remee RA. Head and neck involvement in Wegener granulomatosis. Adv Exp Med Biol 1993;336:309-13.
33. Nishino H, RubinoFA, De Remee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener granulomatosis: an analysis of 324 consecutives patients at the Mayo Clinic. Ann Neurol 1993;33(1):4-9.
34. Rao JK, Weinberger M, Oddone EZ et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. Ann Int Med 1995;123:925-32.
35. Gross WL, Reinhold-Keller E. Anca-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). Z Rheumatol 1995;54(5):279-90.
36. Ibanez T. Granulomatosis de Wegener localizada en fosas nasales. Acta Otorrinolaringolol Esp 1995;46(5):361-4.
37. Groot K, Keller ER, Tatsis E et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Arthritis Rheum 1996;39(12):2052-61.
38. Genereau T, Lortholary O, Leclerq P. Treatment of systemic vasculitis with cyclophosphamide and steroids. Br J Rheumatol 1994;33(10):959-62.
39. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116(6):488-98.
40. Mark EJ, Flieder DB, Matsubara O. Treated Wegener's granulomatosis: distinctive pathological findings in the lungs of 20 patients and what they tell us about the natural history of the disease. Human Pathol 1997;28(4):450-8.
41. Piercey S, Montanaro A. Recurrent Wegener's granulomatosis: a case report and review. Ann Allergy Asthma Immunol 1996; 76(4):317-20.
42. Wrengler E, Pirsch JD, Cangro CB et al. Single-center experience with renal transplantation in patients with Wegener's granulomatosis. Transpl Int 1997;10(2):152-6.
43. Vincent F, Bensoussan TA. Pneumocystis carinii pneumonia: a major complication of immunosupressive therapy in pacients with Wegener's granulomatosis. Am J Resp Crit Care Med 1995; 152(6):2202.
44. Le Thi Tuong D, Wechsler B, Chamuzeau JP, Bisson A, Godeau P. Pulmonary aspergilloma complicating Wegener's granulomatosis. Scand Rheumatol 1995;24(4):260.
45. Gordon C, Luqmari R, Fields P, Howie AJ, Emery P. Two cases of "Wegener's tuberculosis". Br J Rheumatol 1993;32(2):143-9.
46. Jha R, Sharma RK, Haque I, Gupta A, Kher V, Pandey R. Wegener's granulomatosis: diagnostic and therapeutic problems. Indian J Chest Dis Allied Sci 1993;35(4):197-201.
47. Odeh M. Renal cell carcinoma associated with cyclophosphamide therapy for Wegener's granulomatosis. Scand J Rheumatol 1996;25(6):391-3.
48. Stein JP, Skinner EC, Boyd SD, Skinner DG. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases. J Urol 1993;149(3):588-9.
49. Tatar-Williams C, Hijazi YM, Walther MM et. al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996;124(5):477-84.
50. Ryffel B. The carcinogenicity of cyclosporin. Toxicology 1992;73(1):1-22.
51. Rosenkranz HS, Klopman G. A structural analysis of the genotoxic and carcinogenic potentials of cyclosporin A. Mutagenesis 1992;7(2):115-8.
52. Crissman JD, Weiss MA, Gluckman J. Midline granuloma syndrome. A clinicopathologic study of 13 patients. Am J Surg Pathol 1982;6:335-8.
53. Stegman CA, Tervaert JWC, Jong PE, Kallemberg CGM. Trimethoprim-sulfametoxazole (co-trimoxazole) for prevention of relapses of Wegener granulomatosis. N Engl J Med 1996; 335(1):16-20.